Listen "#8 - Sandra von Meier, Head of Business Development at Debiopharm"
Episode Synopsis
Join us on the latest episode! Our Guest: Sandra von Meier, Head of Business Development at DebiopharmWhat you'll get out of this episode:- Sandra's background- Overview of Debiopharm- Tell us about Debiopharm’s approach to drug development. How does it work with startups to enhance innovation and expedite clinical trial timelines?- What steps can companies take to improve patient quality of life in drug development?- As the world continues to face a global drug shortage, how does Debiopharm bridge the gap between disruptive research and real-world application to ensure patients receive the life-saving drugs they need?- What’s next for the future of biopharma?To learn more about Debiopharm: https://www.debiopharm.com/Full Episode and more info here: https://loom.ly/dkKu8RAOur sponsors for this episode are: Sage Growth Partners https://www.sage-growth.comFlipMD by GoodRX https://www.goodrx.com/Quantum Health https://quantum-health.com/
More episodes of the podcast BioBreakthroughs
#48 - Michael Oleksiw, CEO at Pleio
15/04/2025
#44 - Joerg Ahlgrimm, CEO at SK Pharmteco
21/08/2024
ZARZA We are Zarza, the prestigious firm behind major projects in information technology.